New Clinical Guide to Help Manage Pediatric Celiac Disease
Click Here to Manage Email Alerts
The Celiac Disease Foundation and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition have collaborated to develop the NASPGHAN Clinical Guide for Pediatric Celiac Disease, a decision tree tool to help clinicians diagnose and manage children with celiac disease, according to a press release.
“A diagnosis of celiac disease is life-long and given increasing disease prevalence, more pediatricians will require the tools to interpret test data from a variety of sources,” Norelle R. Reilly, MD, NASPGHAN Clinical Guide co-chair and assistant professor of pediatrics at Columbia University, said in the release. “This tool was developed to consolidate current guidelines, research, and expert opinion into an accessible and user-friendly electronic format to address diagnostic dilemmas and improve quality of care.”
Norelle R. Reilly
The NASPGHAN Clinical Guide for Pediatric Celiac Disease, accessible on smartphones and desktop, delivers health care professionals the best and most convenient data available, with frequent updates to reflect any relevant new clinical information and evidence. The Guide provides recommendations for appropriate care for most pediatric patients with celiac disease. As the only approved treatment for celiac disease is adherence to a strict gluten-free diet, early and accurate diagnosis remains critical to effectively treat pediatric celiac disease.
“The average length of time to diagnosis for a symptomatic celiac disease patient is more than four years, and only about one in four people with celiac disease are diagnosed,” Marilyn G. Geller, MSPH, Celiac Disease Foundation CEO, said in the release. “Celiac Disease Foundation is pleased to assist NASPGHAN in offering a tool that can lead to early and increased diagnosis, improving the quality and effectiveness of pediatric patient care.” – by Savannah Demko
Reference:
NASPGHAN Clinical Guide for Pediatric Celiac Disease. www.celiac.org/NASPGHAN. May 23, 2017. Accessed May 31, 2017.
Disclosures: Reilly is a Co-Chair at the NASPGHAN Clinical Guide. Geller is CEO of the Celiac Disease Foundation.